
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Dec 25, 2025 02:02 am UTC| Business
Hyundai Motor has announced a significant vehicle recall in the United States, affecting 51,587 vehicles, after identifying a potential fire hazard linked to faulty trailer wiring installations. According to the U.S....

Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Dec 25, 2025 01:56 am UTC| Technology Business
NVIDIA (NASDAQ: NVDA) has reportedly agreed to acquire Groq, a fast-growing designer of high-performance artificial intelligence accelerator chips, in a $20 billion all-cash transaction, according to a CNBC report. The...

GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Dec 25, 2025 01:49 am UTC| Health Business
Packaged food manufacturers and fast-food restaurants are preparing for major shifts in consumer demand as appetite-suppressing GLP-1 weight loss pills are expected to enter the U.S. market in early 2025. Analysts believe...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Dec 24, 2025 11:06 am UTC| Business Health
Sanofi has announced an agreement to acquire U.S.-based vaccines company Dynavax Technologies in an all-cash transaction valued at approximately $2.2 billion, marking another strategic move to expand its vaccines business....

Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Dec 24, 2025 11:05 am UTC| Business
Nike Inc. (NYSE: NKE) shares climbed more than 2% in pre-market trading on Wednesday after a regulatory filing revealed significant insider buying by Apple Inc. (NASDAQ: AAPL) CEO Tim Cook. The disclosure boosted investor...

BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Dec 24, 2025 05:29 am UTC| Business
A high-profile BlackRock-backed bid to acquire a portfolio of global port assets, including strategically vital facilities linked to the Panama Canal, is reportedly at risk of collapse as negotiations face mounting...

FDA Approves Mitapivat for Anemia in Thalassemia Patients
Dec 24, 2025 05:24 am UTC| Governance Business Health
Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving mitapivat for the treatment of anemia in adults with alpha- or beta-thalassemia. The approval represents...